Literature DB >> 1985490

Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma.

L K Mao1, W C Stewart, M B Shields.   

Abstract

Fifty-five patients with primary open-angle glaucoma and early glaucomatous damage who had medical therapy and laser trabeculoplasty were followed up for four to 11 years or until progressive glaucomatous damage was documented. Factors associated with the stability or progression of glaucoma were evaluated. Eyes with mean intraocular pressure higher than 21 mm Hg during the follow-up period uniformly had progressive glaucomatous changes. Conversely, eyes with mean intraocular pressure less than 17 mm Hg remained stable, and approximately half of the eyes with mean intraocular pressure between 17 and 21 mm Hg had progressive glaucomatous changes. Patients who remained stable were slightly younger than those with progressive glaucomatous changes (P less than .05), but initial optic nerve head appearance, initial visual field findings, number of medicines used, medical history, and patient gender or race were not statistically associated with stability or progression of the glaucoma. These findings reinforce the importance of intraocular pressure control in primary open-angle glaucoma and the need to identify other markers that help determine the proper level of intraocular pressure for individual patients.

Entities:  

Mesh:

Year:  1991        PMID: 1985490     DOI: 10.1016/s0002-9394(14)76896-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  37 in total

1.  Intraocular pressure-related pattern of optic disc cupping in adult glaucoma patients.

Authors:  D H Shin; M K Lee; K S Briggs; C Kim; J H Zeiter; B McCarty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe.

Authors:  J García-Sánchez; J-F Rouland; D Spiegel; B Pajic; I Cunliffe; C Traverso; J Landry
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

3.  Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension.

Authors:  Norbert Pfeiffer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-16       Impact factor: 3.117

Review 4.  Evolving paradigms in the medical treatment of glaucoma.

Authors:  John S Cohen; Anup K Khatana; Linda J Greff
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

5.  Relationship between optic disc cupping change and intraocular pressure control in adult glaucoma patients.

Authors:  E Z Rath; D H Shin; C Kim; C S Tsai; J H Zeiter; Y J Hong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-07       Impact factor: 3.117

6.  A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.

Authors:  S M Whitcup; L B Cantor; A M VanDenburgh; K Chen
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

Review 7.  Glaucoma drainage devices; past, present, and future.

Authors:  K S Lim; B D Allan; A W Lloyd; A Muir; P T Khaw
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

8.  Long-term results of trabeculectomy in eyes that were initially successful.

Authors:  J T Wilensky; T C Chen
Journal:  Trans Am Ophthalmol Soc       Date:  1996

9.  Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom.

Authors:  Z Zhou; R Althin; B S Sforzolini; R Dhawan
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

10.  Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.

Authors:  Kazuyuki Hirooka; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.